Your browser doesn't support javascript.
loading
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.
Pascual-Figal, Domingo; Wachter, Rolf; Senni, Michele; Bao, Weibin; Noè, Adele; Schwende, Heike; Butylin, Dmytro; Prescott, Margaret F.
Afiliação
  • Pascual-Figal D; Cardiology Department, Virgen de la Arrixaca University Hospital, Universidad de Murcia, Murcia, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. Electronic address: dpascual@um.es.
  • Wachter R; Clinic and Policlinic for Cardiology, University Hospital Leipzig, Leipzig, Germany; Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; German Cardiovascular Research Center, partner site Göttingen, Göttingen, Germany.
  • Senni M; Cardiology Division, Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Bao W; Novartis Pharmaceuticals, East Hanover, New Jersey.
  • Noè A; Novartis Pharma AG, Basel, Switzerland.
  • Schwende H; Cardiology Department, Virgen de la Arrixaca University Hospital, Universidad de Murcia, Murcia, Spain.
  • Butylin D; Cardiology Department, Virgen de la Arrixaca University Hospital, Universidad de Murcia, Murcia, Spain.
  • Prescott MF; Novartis Pharmaceuticals, East Hanover, New Jersey.
JACC Heart Fail ; 8(10): 822-833, 2020 10.
Article em En | MEDLINE | ID: mdl-32800508
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article